Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof

Details for Australian Patent Application No. 2006326662 (hide)

Owner Amgen Inc.

Inventors Dao, Jennifer; Tegley, Christopher M.; Mercede, Stephanie J.; Golden, Jennifer E.; Neira, Susana C.; Burli, Roland; Biswas, Kaustav; Muller, Kristine M.; Kurzeja, Robert; Peterkin, Tanya A. N.; Allen, Jennifer R.; Frohn, Michael J.; Yu, Violeta; Hungate, Randall W.

Agent Shelston IP

Pub. Number AU-B-2006326662

PCT Pub. Number WO2007/070359

Priority 60/785,358 24.03.06 US; 60/748,577 09.12.05 US

Filing date 8 December 2006

Wipo publication date 21 June 2007

Acceptance publication date 28 July 2011

International Classifications

C07D 215/22 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61K 31/47 (2006.01) - Quinolines

A61K 31/4709 (2006.01) - Non-condensed quinolines containing further heterocyclic rings

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 405/04 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 409/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

10 July 2008 PCT application entered the National Phase

  PCT publication WO2007/070359 Priority application(s): WO2007/070359

28 July 2011 Application Accepted

  Published as AU-B-2006326662

1 December 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under reg. 22.2I(2). This application has been accepted or advertised accepted. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

12 January 2012 Section 223 Application Allowed

  Amgen Inc. The time in which to pay the acceptance fee has been extended to 28 Nov 2011. Address for service in Australia - Shelston IP Level 21 60 Margaret Street Sydney NSW 2000 2008

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006326665-Indolone compounds useful to treat cognitive impairment

2006326661-Determining advertisements using user interest information and map-based location information